Pharmagenome
Pharmagenome (PGT)
More on ICO
Token Sale May 25, 2018 - June 8, 2018
ICOBench Rating 2.3 / 5 ICOMarks Rating 2.4 / 10
Whitelist/KYC Not needed
Token price 0.0000 USD
Platform Ethereum

A Blockchain based crowdsourced platform for investment and development of an information platform that will alert people to their genetic diseases, guides them with preventive behaviors regarding the way of life and nutrition according to their genetic predispositions in order to escape serious illnesses and help patients select the effective drug and the optimum dose of the drug with respect to their genome. The project is based on Waves platform providing utilities that classical approaches do not utilize to the potential investors.

Team members

AleŇ° Borut Ivanko
CEO
Martina Vrankar
Ales Ivkovic
Tone Rop
Uros Lojk
Web and graphic designer

ICO Advisors

This ICO doesn't have any advisors.
Q3 2017

Ideation.

Q1 2018

Concept Research Start.

May 2018

Token Sale.

Q4 2018

Launch of Beta platform.

May 2019

Marketing & Services.

Q3 2019

Implementation of standard platform.

Q2 2020

Setting up laboratory.

Q4 2020

Growth on global market.